Quest To Pay $6M To End Blood Test FCA Suit
Law360, Los Angeles (April 28, 2017, 8:34 PM EDT) -- Quest Diagnostics Inc. agreed to pay $6 million to escape a long-running False Claims Act suit accusing a company it acquired of shelling out kickbacks to doctors who referred patients for blood tests, the government said Friday.
Quest had acquired Berkeley HeartLab Inc. in 2011 after Dr. Michael Mayes had already lodged his whistleblower suit accusing the lab of paying physicians to refer patients for testing, spurring doctors to send people in for bloodwork that wasn’t necessary, according to a government statement. Quest stopped the kickbacks, but the litigation raged on.
The parties told the court nearly a year ago that...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!